Celltrion, Inc. (KRX:068270)

Celltrion Revenue

Celltrion had revenue of 1.39T KRW in the quarter ending June 30, 2026, with 44.96% growth. This brings the company's total for the last twelve months to 4.90T, up 30.64% year-over-year. In the year 2025, Celltrion had annual revenue of 4.16T with 17.01% growth. That makes Celltrion the 3,292nd largest company in the world by revenue and 132nd in South Korea.

• Revenue (ttm): 4.90T
• Revenue Growth: +30.64%
• P/S Ratio: 8.94
• Revenue / Employee: 1.66B
• Employees: 2,956
• Market Cap: 43.77T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biopharmaceutical Medicines 6.03T 91.5%
• Chemical Medicines 556.71B 8.4%
• Other Segments 6.74B 0.1%

By Geography

Chart

• Europe 2.01T 48.3%
• Domestic 1.26T 30.3%
• North America 419.96B 10.1%
• Asia 309.00B 7.4%
• Central and South America 161.78B 3.9%

Fiscal year ended Dec 31, 2025 See the full Celltrion breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.16T	605.19B	17.01%
Dec 31, 2024	3.56T	1.38T	63.45%
Dec 31, 2023	2.18T	-107.54B	-4.71%
Dec 31, 2022	2.28T	390.57B	20.63%
Dec 31, 2021	1.89T	44.29B	2.39%

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error